Zobrazeno 1 - 10
of 69
pro vyhledávání: '"C.C.M. Bartels"'
Autor:
Mariska den Heijer, Caroline Seynaeve, Aad Tibben, Hugo J. Duivenvoorden, C.C.M. Bartels, Kathleen Vanheusden, Marian B. E. Menke-Pluymers
Publikováno v:
Psycho-Oncology, 20(12), 1317-1323. John Wiley & Sons Ltd.
Background: Hereditary breast cancer has a profound impact on individual family members and on their mutual communication and interactions. The way at-risk women cope with the threat of hereditary breast cancer may depend on the quality of family com
Autor:
R. Kaas, Caroline Seynaeve, Nicoline Hoogerbrugge, Sybren L. Meijer, Mieke Kriege, Rob A. E. M. Tollenaar, Emiel J. T. Rutgers, Jan G. M. Klijn, Martin N. J. M. Wasser, Claudette E. Loo, Harry J. de Koning, Carla Boetes, Inge-Marie Obdeijn, Madeleine M. A. Tilanus-Linthorst, C.C.M. Bartels, Jan C. Oosterwijk, Sara H. Muller, Adriana J. Rijnsburger, E. Bergers, Maartje J. Hooning, Paul I.M. Schmitz, Hans Peterse, Theo Kok
Publikováno v:
Journal of Clinical Oncology, 28(36), 5265-5273
Rijnsburger, A J, Obdeijn, I M, Kaas, R, Tilanus-Linthorst, M M, Boetes, C, Loo, C E, Wasser, M N, Bergers, E, Kok, T, Muller, S H, Peterse, H, Tollenaar, R A, Hoogerbrugge, N, Meijer, S, Bartels, C C, Seynaeve, C, Hooning, M J, Kriege, M, Schmitz, P I, Oosterwijk, J C, Koning, H J, Rutgers, E J & Klijn, JG 2010, ' BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study ', Journal of Clinical Oncology, vol. 28, no. 36, pp. 5265-5273 . https://doi.org/10.1200/JCO.2009.27.2294
Journal of Clinical Oncology, 28, 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 28(36), 5265-5273. American Society of Clinical Oncology
Journal of Clinical Oncology, 28, 36, pp. 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. American Society of Clinical Oncology
Rijnsburger, A J, Obdeijn, I M, Kaas, R, Tilanus-Linthorst, M M, Boetes, C, Loo, C E, Wasser, M N, Bergers, E, Kok, T, Muller, S H, Peterse, H, Tollenaar, R A, Hoogerbrugge, N, Meijer, S, Bartels, C C, Seynaeve, C, Hooning, M J, Kriege, M, Schmitz, P I, Oosterwijk, J C, Koning, H J, Rutgers, E J & Klijn, JG 2010, ' BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study ', Journal of Clinical Oncology, vol. 28, no. 36, pp. 5265-5273 . https://doi.org/10.1200/JCO.2009.27.2294
Journal of Clinical Oncology, 28, 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 28(36), 5265-5273. American Society of Clinical Oncology
Journal of Clinical Oncology, 28, 36, pp. 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. American Society of Clinical Oncology
Purpose The Dutch MRI Screening Study on early detection of hereditary breast cancer started in 1999. We evaluated the long-term results including separate analyses of BRCA1 and BRCA2 mutation carriers and first results on survival. Patients and Meth
Autor:
Rob J. de Boer, Rianne de Gelder, Elisabeth van As, Madeleine M.A. Tilanus-Linthorst, Harry J. de Koning, Gerrit Draisma, C.C.M. Bartels
Publikováno v:
International Journal of Cancer. 123:680-686
Tumour stage distribution at repeated mammography screening is, unexpectedly, often not more favourable than stage distribution at first screenings. False reassurance, i.e., delayed symptom presentation due to having participated in earlier screening
Autor:
J.G.M. Klijn, Marian B. E. Menke-Pluymers, Hanne Meijers-Heijboer, Curt W. Burger, C.C.M. Bartels, A.M.M. Eggermont, A.N. van Geel, M.M.A. Tilanus-Linthorst, Mieke Kriege, Caroline Seynaeve, A. vd Ouweland, C.T.M. Brekelmans
Publikováno v:
European Journal of Cancer, 43(5), 867-876. Elsevier Ltd.
European journal of cancer (Oxford, England, 43(5), 867-876. Elsevier Limited
European journal of cancer (Oxford, England, 43(5), 867-876. Elsevier Limited
Aim of the study Results on tumour characteristics and survival of hereditary breast cancer (BC), especially on BRCA2-associated BC, are inconclusive. The prognostic impact of the classical tumour and treatment factors in hereditary BC is insufficien
Autor:
Madeleine M.A. Tilanus-Linthorst, Cecile T. M. Brekelmans, Jan G. M. Klijn, Caroline Seynaeve, C.C.M. Bartels, M. B. M. Tan, Bernadette A M Heemskerk-Gerritsen, Marian B. E. Menke-Pluymers, Albert N. van Geel, Hanne Meijers-Heijboer
Publikováno v:
Annals of surgical oncology, 14(12), 3335-3344. Springer New York
Annals of Surgical Oncology, 14(12), 3335-3344. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 14(12), 3335-3344. Springer New York
Annals of Surgical Oncology
Background BRCA1/2 mutation carriers and women from a hereditary breast(/ovarian) cancer family have a highly increased risk of developing breast cancer (BC). Prophylactic mastectomy (PM) results in the greatest BC risk reduction. Long-term data on t
Autor:
Caroline Seynaeve, H.J. de Koning, J.G.M. Klijn, Aad Tibben, K. Pieterse, Adriana J. Rijnsburger, C.C.M. Bartels, T. van Elderen, S. van Dooren, Hugo J. Duivenvoorden
Publikováno v:
Psycho-Oncology, 61, 851-858. John Wiley & Sons Ltd.
Since 2000 the MRISC study evaluates the psychological consequences of regular breast cancer surveillance for women at increased risk for hereditary breast cancer. Coping style may influence these psychological consequences. In a cohort of 357 women
Autor:
Nicoline Hoogerbrugge, A. Peter E. Besnard, Siebren Meijer, Radu A. Manoliu, H. M. Zonderland, Inge Marie Obdeijn, Mieke Kriege, Jan G. M. Klijn, Caroline Seynaeve, Jan C. Oosterwijk, Sara H. Muller, Reini Kaas, Madeleine M.A. Tilanus-Linthorst, Harry J. de Koning, Rob A. E. M. Tollenaar, Theo Kok, Emiel J. Th. Rutgers, Cecile T. M. Brekelmans, C.C.M. Bartels, Carla Boetes
Publikováno v:
Breast Cancer Research and Treatment, 100, 1, pp. 109-19
Breast Cancer Research and Treatment, 100, 109-19
Breast Cancer Research and Treatment, 100(1), 109-119. SPRINGER
Breast cancer research and treatment, 100(1), 109-119. Springer New York
Breast Cancer Research and Treatment, 100(1), 109-119. Springer New York
Breast Cancer Research and Treatment, 100, 109-19
Breast Cancer Research and Treatment, 100(1), 109-119. SPRINGER
Breast cancer research and treatment, 100(1), 109-119. Springer New York
Breast Cancer Research and Treatment, 100(1), 109-119. Springer New York
Contains fulltext : 49322.pdf (Publisher’s version ) (Closed access) BACKGROUND: The MRISC study is a screening study, in which women with an increased risk of hereditary breast cancer are screened by a yearly mammography and MRI, and half-yearly c
Autor:
Nicoline Hoogerbrugge, Sybren L. Meijer, H.J. de Koning, Jan C. Oosterwijk, Theo Kok, Carla Boetes, H. M. Zonderland, A. P. E. Besnard, Caroline Seynaeve, Inge Marie Obdeijn, R. A. Manoliu, Mieke Kriege, Hans Peterse, Madeleine M. A. Tilanus-Linthorst, Sara H. Muller, E.J.T. Rutgers, C.C.M. Bartels, J.G.M. Klijn, C.T.M. Brekelmans, Rob A. E. M. Tollenaar
Publikováno v:
Breast cancer research and treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102, 357-63
Breast Cancer Research and Treatment, 102(3), 357-363. SPRINGER
Breast Cancer Research and Treatment, 102, 3, pp. 357-63
Breast Cancer Research and Treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102, 357-63
Breast Cancer Research and Treatment, 102(3), 357-363. SPRINGER
Breast Cancer Research and Treatment, 102, 3, pp. 357-63
In the MRISC study, women with an inherited risk for breast cancer were screened by a 6-month clinical breast examination (CBE) and yearly MRI and mammography. We found that the MRISC screening scheme could facilitate early breast cancer diagnosis an
Autor:
H.J. de Koning, Marie-Louise Essink-Bot, Adriana J. Rijnsburger, Aad Tibben, S. van Dooren, Gerard J. J. M. Borsboom, Caroline Seynaeve, J.G.M. Klijn, C.C.M. Bartels
Publikováno v:
British Journal of Cancer, 91, 69-76. Nature Publishing Group
British journal of cancer, 91(1), 69-76. Nature Publishing Group
British Journal of Cancer
British journal of cancer, 91(1), 69-76. Nature Publishing Group
British Journal of Cancer
The effectiveness of intensive surveillance in women at high risk for breast cancer due to a familial or genetic predisposition is uncertain and is currently being evaluated in a Dutch magnetic resonance imaging (MRI) screening (MRISC) study, in whic
Autor:
H.J. de Koning, A. Kriege, Hugo J. Duivenvoorden, Aad Tibben, S. van Dooren, Marie-Louise Essink-Bot, C.C.M. Bartels, Adriana J. Rijnsburger, Caroline Seynaeve
Publikováno v:
Community genetics, 6(4), 235-241. S. Karger AG
Community Genetics, 6(4), 235-241. Karger
Community Genetics, 6(4), 235-241. Karger
Background: The Magnetic Resonance Imaging Screening study evaluates the efficacy and psychological impact of a surveillance program for women at increased risk for hereditary or familial breast cancer in the Netherlands. Surveillance consists of bia